Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPets at home Regulatory News (PETS)

Share Price Information for Pets at home (PETS)

Share Price is delayed by 15 minutes
Get Live Data
183.40    -2.40 (-1.29%)
Bid:
182.00
Ask:
184.10
Spread: 2.10 (1.154%)
Market Cap: £811.14m
PETS Live PriceLast checked at - London Stock Exchange

Intraday Pets at home Share Chart

Directorate Change

1 Nov 2023 07:00

RNS Number : 9460R
Pets At Home Group Plc
01 November 2023
 

 

 

FOR IMMEDIATE RELEASE 1 November 2023

Pets at Home Group Plc: Directorate Change

Pets at Home Group plc, the UK's leading pet care business, announces a change to its Board of Directors with the appointment of a new independent Non-Executive Director.

Angelique Augereau will be appointed as an independent Non-Executive Director with effect from 22 January 2024.

 

On her appointment to the Board, Angelique will also become a member of the Nomination and Corporate Governance Committee and the ESG Committee.

 

Until recently, Angelique was Chief Analytics Officer at Capital One Financial Corporation, where she led a team executing Capital One's first artificial intelligence and machine learning strategy and innovation agenda for the Card business. Previously, Angelique was the Chief Data & Analytics Officer for Apax Partners and Managing Director in JP Morgan's Global Payment Business where she built and scaled a data-driven innovation unit. Angelique has a Ph.D. in Economics and Strategy from J. L. Kellogg Graduate School of Management-Northwestern University, Evanston.

 

 

Ian Burke, Chair of Pets at Home, commented:

"On behalf of the Board, I am delighted to welcome Angelique Augereau to Pets at Home Group plc. The directors and I look forward to Angelique joining our Board of Directors and strengthening the Board's experience in AI and machine learning."

Further changes

 

In addition, as originally announced on 21 December 2022, Dennis Millard will step down from the Board on 29 February 2024. The Directors, on behalf of the Company, wish to thank Dennis for his dedicated service. 

 

This disclosure is given in accordance with Listing Rule 9.6.11.

 

 

Enquiries

Pets at Home Group Plc:

Lesley Lazenby, Company Secretary

+44 (0)161 468 6688

 

Investor Relations/Media Enquiries Pets at Home Group Plc:

Andrew Porteous, Director of Investor Relations+44 (0)161 468 6688

Natalie Cullington, Head of Media & Corporate Affairs +44 (0)161 468 6688

 

About Pets At Home

Pets at Home Group Plc is the UK's leading pet care business; our commitment is to make sure pets and their owners get the very best advice, products and care. Pet products are available online or from our 459 stores, many of which also have vet practices and grooming salons. Pets at Home also operates a UK leading small animal veterinary business, with 447 First Opinion practices located both in our stores and in standalone locations. For more information visit: http://investors.petsathome.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFFFFIIILLVIV
Date   Source Headline
27th May 20267:00 amRNSFY26 Preliminary Results
8th Apr 20261:47 pmRNSHolding(s) in Company
8th Apr 20267:00 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSFY26 pre-close statement
3rd Mar 20267:00 amRNSTotal Voting Rights
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTotal Voting Rights
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSQ3 FY26 Trading Statement
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSConfirmation of Board Changes
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
23rd Dec 20257:00 amRNSAppointment of CEO

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.